Low-Molecular-Weight Heparins (LMWH) and Synthetic Factor X Inhibitors Can Impair the Osseointegration Process of a Titanium Implant in an Interventional Animal Study.
Article in Medicina (Kaunas, Lithuania), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 74% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 0 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors at 4 institutions in 1 country.
Dragos ApostuDepartment of Orthopedics, Traumatology and Pediatric Orthopaedics, University of Medicine and Pharmacy Cluj-Napoca, 400347 Cluj-Napoca, Romania.ORCID 0000-0001-9046-9432
Bianca BerechetDepartment of Gastroenterology, "Octavian Fodor" Institute of Gastroenterology and Hepatology, 400347 Cluj-Napoca, Romania.
Daniel Oltean-DanDepartment of Orthopedics, Traumatology and Pediatric Orthopaedics, University of Medicine and Pharmacy Cluj-Napoca, 400347 Cluj-Napoca, Romania.ORCID 0000-0002-8094-8963
Alexandru MesterDepartment of Oral Health, University of Medicine and Pharmacy Cluj-Napoca, 400012 Cluj-Napoca, Romania.ORCID 0000-0002-3393-4307
Bobe PetrushevDepartment of Gastroenterology, "Octavian Fodor" Institute of Gastroenterology and Hepatology, 400347 Cluj-Napoca, Romania.
Catalin PopaDepartment of Materials Science and Engineering, Technical University of Cluj-Napoca, 400114 Cluj-Napoca, Romania.
Madalina Luciana GhermanExperimental Center, University of Medicine and Pharmacy Cluj-Napoca, 400012 Cluj-Napoca, Romania.ORCID 0000-0002-8976-1011
Adrian Bogdan TiguResearch Center for Advanced Medicine-MedFuture, Department of Translational Medicine, University of Medicine and Pharmacy Cluj-Napoca, 400347 Cluj-Napoca, Romania.ORCID 0000-0001-9397-0791
Ciprian Ionut TomuleasaDepartment of Hematology, University of Medicine and Pharmacy Cluj-Napoca, 400012 Cluj-Napoca, Romania.ORCID 0000-0001-5500-1519
Lucian Barbu-TudoranElectron Microscopy Center, Faculty of Biology and Geology, Babes-Bolyai University, 400006 Cluj-Napoca, Romania.
Horea Rares Ciprian BeneaDepartment of Orthopedics, Traumatology and Pediatric Orthopaedics, University of Medicine and Pharmacy Cluj-Napoca, 400347 Cluj-Napoca, Romania.
Doina PiciuNuclear Medicine Department, University of Medicine and Pharmacy Cluj-Napoca, 400012 Cluj-Napoca, Romania.ORCID 0000-0001-6184-7449
University of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca · ROInstitutul Regional de Gastroenterologie Prof. Dr. Octavian Fodor · ROBabeș-Bolyai University · ROTechnical University of Cluj-Napoca · RO
Funding
Novo Nordisk Haemophilia Foundation Romanian Hematology Society - Romania 4Romanian Ministry of Education and Research PN-III-P1-1.1-PD-2019-0124
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
NadroparinVenous ThromboembolismAnimalsAnticoagulantsEnoxaparinFactor XFemaleFondaparinuxOsseointegrationRatsTitaniumAnticoagulantsEnoxaparinFactor XFondaparinuxNadroparinTitaniumaseptic looseningcementless hip arthroplastyenoxaparinfondaparinuximplant osseointegrationnadroparin
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Low-Molecular-Weight Heparins (LMWH) and Synthetic Factor X Inhibitors Can Impair the Osseointegration Process of a Titanium Implant in an Interventional Animal Study. · full record | OpenQuestion